The management of the cost and utilisation of pharmaceuticals in the United Kingdom

Health Policy

Volumn 41, Issue SUPPL., 1997, Pages

  Burstall, Michael L ^a  

^a REMIT Consultants Ltd   (United Kingdom)

Author keywords

National Health Service; Pharmaceutical cost containment; Price control

Indexed keywords

DRUG COST; GENERAL PRACTITIONER; HEALTH CARE COST; MEDICAL EDUCATION; PRESCRIPTION; REVIEW; UNITED KINGDOM;

EID: 0030772912     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(97)00051-1     Document Type: Article

References (25)

1. Office of Health Economics, Compendium of Health Statistics, 9th Edition, London, 1995, Table 2.1.
2. Compendium of Health Statistics, op. cit., Note 1, Tables 3.9, 4.5.
3. Author's estimates based on Association of the British Pharmaceutical Industry (ABPI). Pharma Facts and Figures, Table 1, and additional information from the ABPI and the Proprietary Association of Great Britain, 1993.
4. UK Department of Health Statistical Bulletin: Prescriptions Dispensed by Pharmacy and Appliance Contractors, England 1984-1994, London, 1995, passim; Compendium of Health Statistics, op. cit., Note 1, Table 4.37.
5. UK Department of Health Statistical Bulletin: Prescriptions Dispensed by Pharmacy and Appliance Contractors, England 1984-1994, London, 1995, passim; Compendium of Health Statistics, op. cit., Note 1, Table 4.37.
6. Ibid, Institute Belge de l'Economie du Sant: Health Statistics Compendium 1994, Fig. 4.14; summarised in Scrip, 6/12/1994, 1981.
7. Farmindustria, Indicators Farmaceutici 1993, Rome, 1993, Table 28.
8. Author's estimates from Compendium of Health Statistics, op. cit., Note 1, Tables 4.25 and 4.26.
9. Statistical Bulletin 1994, op. cit., Note 4; ABPI, Trends in the usage of prescription medicines by the elderly and very elderly between 1977 and 1988, London, 1989.
10. Syndicat National de L'Industrie Pharmaceutique, The French Pharmaceutical Industry: Facts and Figures 1995, Paris, Table 39; information from the German pharmacists' association ABDA.
11. Booer, T. In: Hoffmeyer UK, McCarthy TR, editors. Financing Health Care, vol. 2. Dordrecht: Kluwer Academic, 1994: 1073-1148; Burstall ML, Reuben BG. Critics of the Pharmaceutical Industry, London: REMIT Consultants, 1990: 75-77, 87-90.
12. Booer, T. In: Hoffmeyer UK, McCarthy TR, editors. Financing Health Care, vol. 2. Dordrecht: Kluwer Academic, 1994: 1073-1148; Burstall ML, Reuben BG. Critics of the Pharmaceutical Industry, London: REMIT Consultants, 1990: 75-77, 87-90.
13. Lang RW. The Politics of Drugs, 1974, Farnborough: Saxon House, 1974:133, 188 and 257-292.
14. Author's estimates from the data given in the French Pharmaceutical Industry, op. cit., Note 9 above, and information from the ABPI.
15. Pharma Facts and Figures, op. cit., Note 3, Figure 15, Table 20.
16. Department of Health. The Pharmaceutical Price Regulation Scheme 1993, London: HMSO. House of Commons Health Committee: Priority Setting in the NHS - The NHS Drugs Budget, London: HMSO, 1994:14-23.
17. Priority Setting, op. cit., Note 14; REMIT Consultants for the American Pharmaceutical Group, American Pharmaceutical Companies in the UK and Europe, London, 1994:11-14.
18. Priority Setting, op. cit., Note 14, 19.
19. Personal information from the European Generic Manufacturers' Association.
20. Department of Health. Statistical Bulletin - Prescriptions dispensed by Pharmacy and Appliance Contractors, 1990, 1994.
21. Burstall ML, Senior IST. Undermining Innovation: Parallel Trade in Prescription Medicines. London: Institute of Economic Affairs, 1992.
22. Department of Health. Working with Patients - Working Paper 5: Indicative Prescribing Budgets for General Medical Practitioners. London: HMSO, 1989.
23. Compendium of Health Statistics, op. cit., Note 1, Box 4-20.
24. UK Department of Health, Prescribe UK, London, 1995.
25. UK Audit Commission. A Prescription for Improvement: Towards more Rational Prescribing in General Practice. London: HMSO, 1994.